Published 2011 | Version v1
Publication

MEK inhibitor as a single agent and in combination with everolimus or sorafenib in a panel of colorectal cancer cell lines: implication for multitargeted approach

Additional details

Created:
April 14, 2023
Modified:
November 29, 2023